Found: 33
Select item for more details and to access through your institution.
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 7, p. 1, doi. 10.1007/s00520-023-07870-9
- By:
- Publication type:
- Article
Response to Cleary et al. re MASCC evidence-based recommendations for the management of malignant bowel obstruction.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 10, p. 7825, doi. 10.1007/s00520-022-07304-y
- By:
- Publication type:
- Article
MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-30081-5
- By:
- Publication type:
- Article
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25432-7
- By:
- Publication type:
- Article
Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231157644
- By:
- Publication type:
- Article
Angiogenesis Inhibitors as Anti-Cancer Therapy Following Renal Transplantation: A Case Report and Review of the Literature.
- Published in:
- Current Oncology, 2021, v. 28, n. 1, p. 661, doi. 10.3390/curroncol28010064
- By:
- Publication type:
- Article
F18-choline, a novel PET tracer for parathyroid adenoma?
- Published in:
- 2013
- By:
- Publication type:
- journal article
Novel Molecular Targets in Endometrial Cancer: Mechanisms and Perspectives for Therapy.
- Published in:
- Biologics: Targets & Therapy, 2024, v. 18, p. 79, doi. 10.2147/BTT.S369783
- By:
- Publication type:
- Article
Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.
- Published in:
- Obstetrics & Gynecology International, 2018, p. 1, doi. 10.1155/2018/1867238
- By:
- Publication type:
- Article
Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.
- Published in:
- Canadian Journal of Surgery, 2023, v. 66, n. 3, p. E310, doi. 10.1503/cjs.017020
- By:
- Publication type:
- Article
Predicting Toxicity and Response to Pembrolizumab Through Germline Genomic HLA Class 1 Analysis.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 1, p. 1, doi. 10.1093/jncics/pkaa115
- By:
- Publication type:
- Article
Immune checkpoint inhibitor-related myocarditis: an illustrative case series of applying the updated Cardiovascular Magnetic Resonance Lake Louise Criteria.
- Published in:
- European Heart Journal Case Reports, 2022, v. 6, n. 1, p. 1, doi. 10.1093/ehjcr/ytab478
- By:
- Publication type:
- Article
Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1122, doi. 10.3390/cancers14051122
- By:
- Publication type:
- Article
Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 416, doi. 10.3390/cancers11030416
- By:
- Publication type:
- Article
Two novel variants in the 3′UTR of the BRCA1 gene in familial breast and/or ovarian cancer.
- Published in:
- 2011
- By:
- Publication type:
- Report
Predictive Relevance of Circulating miR-622 in Patients with Newly Diagnosed and Recurrent High-Grade Serous Ovarian Carcinoma.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 2, p. 352, doi. 10.1093/clinchem/hvz013
- By:
- Publication type:
- Article
The motivations and methodology for high-throughput PET imaging of small animals in cancer research.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 9, p. 1497, doi. 10.1007/s00259-012-2177-x
- By:
- Publication type:
- Article
Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00119
- By:
- Publication type:
- Article
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.
- Published in:
- BJU International, 2015, v. 115, n. 1, p. 65, doi. 10.1111/bju.12552
- By:
- Publication type:
- Article
Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: An ex vivo experiment in human serous ovarian carcinoma.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 5, p. E340, doi. 10.1002/ijc.29104
- By:
- Publication type:
- Article
Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer.
- Published in:
- Drug Design, Development & Therapy, 2018, v. 12, p. 605, doi. 10.2147/DDDT.S130809
- By:
- Publication type:
- Article
Ovarian cancer treatment: The end of empiricism?
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 18, p. 3203, doi. 10.1002/cncr.29481
- By:
- Publication type:
- Article
Platinum compounds sensitize ovarian carcinoma cells to ABT-737 by modulation of the Mcl-1/Noxa axis.
- Published in:
- Apoptosis, 2013, v. 18, n. 4, p. 492, doi. 10.1007/s10495-012-0799-x
- By:
- Publication type:
- Article
Evaluation of toxicities related to novel therapy in clinical trials for women with gynecologic cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
FDG PET/CT for assessing tumour response to immunotherapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 1, p. 238, doi. 10.1007/s00259-018-4171-4
- By:
- Publication type:
- Article
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1439, doi. 10.1093/jnci/djae098
- By:
- Publication type:
- Article
Author Correction: Inhibition of nicotinamide dinucleotide salvage pathway counters acquired and intrinsic poly(ADP-ribose) polymerase inhibitor resistance in high-grade serous ovarian cancer.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
- By:
- Publication type:
- Article
Epithelial ovarian cancer: Evolution of management in the era of precision medicine.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges.
- Published in:
- International Journal of Women's Health, 2022, v. 14, p. 1849, doi. 10.2147/IJWH.S366680
- By:
- Publication type:
- Article
Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario.
- Published in:
- Current Oncology, 2022, v. 29, n. 8, p. 5988, doi. 10.3390/curroncol29080472
- By:
- Publication type:
- Article
Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 7, p. 981, doi. 10.1016/j.molonc.2016.03.005
- By:
- Publication type:
- Article